Riding reforms for drug innovation

Du Ying leads Zai Lab to excel in biopharmaceutical industry in China

Du Ying, a biotech scientist and chairwoman of Zai Lab, a Shanghai-and San Francisco-based biopharmaceutical company, is quite excited about the latest developments in her industry. She and her colleagues have been using their expertise to bring transformative medicines to cancer, autoimmune and infectious disease patients in China.

The company focuses on discovering, licensing, developing and commercializing proprietary therapeutics for large unmet medical needs in China in areas such as oncology, autoimmune and infectious diseases.